914 search results for “optimize drug design” in the Staff website
-
Chenyu ShiFaculty of Science
c.shi@liacs.leidenuniv.nl | 071 5272727
-
Learning Experience Design
Didactics
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
Han YuFaculty of Science
h.yu@cml.leidenuniv.nl | 071 5272727
-
Tianyuan WangFaculty of Science
t.wang@liacs.leidenuniv.nl | 071 5272727
-
Andrea Herrera JaramilloFaculty of Science
j.a.herrera.jaramillo@cml.leidenuniv.nl | 071 5272727
- Test design
- Educational design
-
Educational design
On this page you find relevant information about (re)designing education. SEEDS offers didactical and technical support for the implementation of improvements in your course.
-
Zhuang KangFaculty of Science
z.kang@liacs.leidenuniv.nl |
-
Joran LammersFaculty of Science
j.a.lammers@cml.leidenuniv.nl | 071 5272727
-
Nusa ZidaricFaculty of Science
n.zidaric@liacs.leidenuniv.nl | 071 5274799
-
Joost GrootensFaculty of Humanities
j.grootens@hum.leidenuniv.nl | 071 5272727
-
Design and advertisements
The Strategic Communication & Marketing (SCM) department and the Graphic Centre of the University Services Department (UFB) support the faculties and other organisational units with regards to printed materials and advertisements.
-
How to design a course (UTQ module)
Didactics
-
How to design a course (UTQ module)
Didactics
-
Ivan Olarte RodriguezFaculty of Science
i.olarte.rodriguez@liacs.leidenuniv.nl | 071 5272727
-
Bartolomeus Häussling LöwgrenFaculty of Science
b.j.p.m.haussling.lowgren@cml.leidenuniv.nl | 071 5272727
-
Individualization of Drug Clearance Predictions and Dose Regimens in Patients with Obesity Using Pharmacometric Approaches
PhD defence
-
using fluorescent cell models for mechanistic evaluation of adverse drug reactions
PhD defence
-
Dirk van der HoevenFaculty of Science
d.van.der.hoeven@math.leidenuniv.nl | 071 5277146
-
Teaching professionals: how to improve your course design
Didactics
-
Yingjie FanFaculty of Science
y.fan@liacs.leidenuniv.nl | 071 5274799
-
Developing drugs with artificial intelligence
Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that can help make drug design cheaper and faster. PhD defence on 15 February.
-
Wet felting workshop: design your own case or bag
Arts and leisure, Arts and leisure
-
New potential drug suppresses chemotherapy induced neuropathic pain
Oncode Investigator Mario van der Stelt and his colleagues have discovered a new potential drug that suppresses chemotherapy induced neuropathic pain.
-
Qianpu ChenFaculty of Science
q.chen.15@liacs.leidenuniv.nl | 071 5272727
-
Abolfazl SajadiFaculty of Science
a.sajadi@liacs.leidenuniv.nl | 071 5274799
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Silke RiceFaculty of Science
s.s.rice@liacs.leidenuniv.nl | 071 5272727
-
Oisin Flynn-ConnollyFaculty of Science
o.c.flynn-connolly@liacs.leidenuniv.nl | 071 5272727
-
Mini organs-on-chips: an alternative to drug testing on animals
Mini organs-on-chips allow us to study how diseases develop and how drugs work. Although the technology is not new, it is becoming increasingly advanced. PhD candidate Bart Kramer hopes it will eliminate animal testing in the future.
-
Joost BatenburgFaculty of Science
k.j.batenburg@liacs.leidenuniv.nl | 071 5276985
-
Artificial intelligence as the co-pilot for drug discovery
There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those molecules? Professor of AI and Medicinal Chemistry, Gerard van Westen: ‘I’m going to use artificial intelligence as the co-pilot to make an automated search.’…
-
Vlad AndriiashenFaculty of Science
-
Mohsen MohammadiFaculty of Social and Behavioural Sciences
m.mohammadi@fsw.leidenuniv.nl | 071 5272727
-
Peter BouwmanFaculty of Science
r.j.p.bouwman@lacdr.leidenuniv.nl | 071 5276105
-
Hildert BronkhorstFaculty of Science
h.bronkhorst@biology.leidenuniv.nl | 071 5274964
-
Oscar RuedaFaculty of Science
o.rueda@cml.leidenuniv.nl | 071 5272727
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.
-
LACDR PhD Introductory course on Drug Research
Recently, we had the LACDR PhD Introductory course on Drug Research for starting PhD candidates. It was great to have this live event live in castle Oud Poelgeest, after two years of restrictions.
-
PhD Introductory Course on Drug Research
At the end of February, we had the PhD Introductory Course on Drug Research for starting PhD candidates from LACDR. This 3-days event took place at Castle Oud Poelgeest, a great location to be completely out of the work environment. We welcomed 30 PhD candidates, with whom we had an inspiring and…
-
LACDR PhD Introductory Course on Drug research
Due to the great influx of PhD candidates, we had the pleasure to organize a 2nd PhD Introductory Course on Drug research this year. From November 4- 6, we welcomed 30 participants for this 3-days event, which took place at Castle Oud Poelgeest.
-
LACDR PhD Introductory course on Drug Research
This week, we had the LACDR PhD Introductory course on Drug. This is always a great opportunity for starting PhD candidates to get to know LACDR, CHDR, the Clinical Pharmacology department of LUMC and the embedding of the institute in the BioSciencepark as a whole.
-
Growth Fund invests many millions in faster and more sustainable (cancer) drug development
On 14 April, the National Growth Fund awarded million euros in grants to two consortia in which Leiden's science faculty is involved. Pharma-NL will receive 80 million euros and Oncode-PACT 325 million euros. Pharma-NL wants to make medicines available to the patient faster and more sustainably. Oncode-PACT…
-
Simulation of infant gut makes predictions about optimal milk
David Versluis successfully simulated an infant gut virtually. This is crucial for research on improvements in formula milk. Currently, such research primarily relies on diaper contents, which is not optimal. Versluis defended his doctoral thesis on April 23.
-
Ben van WerkhovenFaculty of Science
b.van.werkhoven@liacs.leidenuniv.nl | 071 5272727
-
Giulia CallegaroFaculty of Science
g.callegaro@lacdr.leidenuniv.nl | 071 5276105
-
LACDR PhD introductory course on drug research
Due to the corona pandemic and the uncertainty of the circumstances end of January 2022, is decided to postpone the LACDR PhD introductory course.
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.